Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area… read more →
Exclusive interview with Taj Pharmaceuticals’ CEO Abhishek Singh. In an exclusive interview, Abhishek Singh, recently expanded his role to Global CEO of Taj Pharma Group talks to CEO Magazine, about the challenges that lie ahead.
Taj Pharmaceuticals Limited (Taj Active Ingredients-Taj API) is a manufacturer of Bulk Drugs / API’s & It’s Intermediates and API Contract Manufacturing Services. Taj Pharmaceuticals company was founded in the year 1995 by renowned Mumbai Based Entrepreneur Dr R K SINGH(Chairman, Taj Pharma Group), the former associated with the Indian Institute of Medical Sciences in New Delhi. Taj Pharma Company Bulk Drug has an experienced and reputed scientific leadership team with strong client relationships with both big pharma and biotech companies. Taj Pharmaceuticals India has three manufacturing facilities two located in Valsad (One facility USFDA approved) and one located in Daman. Infrastructure spread over 8 locations in Gujarat and Maharashtra; API Facility is 30 acres with reactor volume of 175000 Liters. Facilities are certified with ISO 9001 and the company follows cGLP and cGMP practices.